Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
about
Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.Annexin 2A sustains glioblastoma cell dissemination and proliferation.Differences in Zbtb7a expression cause heterogeneous changes in human nasopharyngeal carcinoma CNE3 sublines.Extracellular vesicles released from cells exposed to reactive oxygen species increase annexin A2 expression and survival of target cells exposed to the same conditions.MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity.Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer.Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer.Identification of natural compounds targeting Annexin A2 with an anti-cancer effect.Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in TaiwanANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
P2860
Q38621653-A9BB76CB-5AD2-485F-8229-DAF404373DF2Q38840667-5F3EC4A6-B8B6-4902-9C97-CC552C0B27DBQ41613027-34C57FD0-83A1-4F31-A3D5-334CB98EF392Q41712023-BBC618F2-A7C3-4BE1-98CB-5C6BE3EB90FEQ42259492-069DCA66-02E1-48DA-A5C8-4F8D389AB8ADQ42367776-E06BC670-E582-412D-A97A-3A73D5799C24Q42370180-703A55A2-2B2C-4A6B-B9EE-9764AE16027EQ47107606-19FE5780-DCC3-43C9-B864-41AB6A791C8FQ49334888-6E1099C5-F6A0-4598-856C-5A18E7065995Q52672650-56E6C322-AE9F-490E-8492-B008DC08FCB8Q53700212-4826BBD9-5B97-401B-BA3D-4D5B9848DE10Q58759213-97DC47D4-45B7-4CF0-AEED-F5D967D8F8F7Q58798837-76151034-327D-4320-9BEA-C8417DE4845F
P2860
Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@ast
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@en
type
label
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@ast
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@en
prefLabel
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@ast
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Targeting annexin A2 reduces t ...... e of nasopharyngeal carcinoma.
@en
P2093
Chang-Fan Li
Chang-Yu Chen
Chi-Long Chen
Chia-Chun Kuo
Chien-Ho Chen
Fei-Peng Lee
Jeng-Fong Chiou
Pin-Zhir Chao
Yin-Ju Chen
Yu-Hsuan Sung
P2860
P304
26946-26959
P356
10.18632/ONCOTARGET.4521
P407
P577
2015-07-09T00:00:00Z